Three companies pushing the field of psychedelic medicine forward to present at Proactive virtual conference on February 23
Hear executives from Silo Pharma and Lobe Sciences at Proactive's psychedelic-themed virtual...
Hear from executives at Aion Therapeutic, Lobe Sciences and Silo Pharma at Proactive's...
Through its Bioscience lab, Numinus is the first public company in Canada to receive a licence...
The New York City-based company has several projects in various stages from planning to ongoing...
The company owns 80% of Pharmadrug GmbH, a German medical cannabis distributor, with a Schedule...
Numinus Wellness (CVE: NUMI) CEO Payton Nyquvest joined Steve Darling from Proactive to share news the company has received amendments to their licensing that will now allow the company to enhance their ability to lead psychedelics research and support the global psychedelics sector. Nyquvest...
Market Report
Market Report
Mining
